India Strengthens Livestock Biotechnology: Indigenous Production of Veterinary Hormones by Biovet Pvt. Ltd.

 



India Strengthens Livestock Biotechnology: Indigenous Production of Veterinary Hormones by Biovet Pvt. Ltd.

Introduction

India’s livestock sector plays a crucial role in the country’s agricultural economy, supporting millions of farmers and contributing significantly to food security and rural livelihoods. Recognizing the importance of strengthening animal healthcare infrastructure, the Technology Development Board (TDB) under the Department of Science & Technology (DST), Government of India, has extended financial assistance to Biovet Private Limited, Malur.

The project titled “Development and Commercialization of Veterinary Hormones” aims to establish an indigenous manufacturing facility for critical veterinary reproductive hormones. These include Gonadorelin, Buserelin acetate (GnRH analogues), and Cloprostenol (a prostaglandin analogue)—essential hormones used in livestock reproduction management and treatment of reproductive disorders.

This initiative represents an important step towards self-reliance in veterinary biotechnology, aligning with India’s broader vision of Aatmanirbhar Bharat.

Background

India possesses the largest livestock population in the world, including cattle, buffaloes, goats, sheep, and poultry. The livestock sector contributes significantly to agricultural GDP and provides income security to millions of small and marginal farmers.

However, despite the scale of India’s animal husbandry sector, the country has historically relied heavily on imported veterinary hormones used for reproductive management, breeding programs, and therapeutic interventions.

These hormones play an essential role in:

  • Artificial insemination programs

  • Estrus synchronization

  • Treatment of infertility in livestock

  • Improving breeding efficiency

Due to the absence of indigenous commercial-scale production, farmers often face high costs and limited availability of these hormones.

To address this gap, the Technology Development Board has supported Biovet Pvt. Ltd., a biotechnology company with expertise in veterinary vaccines and biological products, to establish a dedicated facility for domestic hormone production.

Objectives of the Project

The initiative aims to achieve several strategic and technological objectives:

1. Indigenous Manufacturing Capacity

Establish a commercial-scale facility for the production of key veterinary reproductive hormones within India.

2. Import Substitution

Reduce dependence on imported veterinary hormones and strengthen domestic biotechnology capabilities.

3. Affordable Access for Farmers

Lower the cost of reproductive therapeutics, making them more accessible to livestock farmers.

4. Strengthening Biotechnology Infrastructure

Expand India’s capacity in bioengineering and hormone synthesis technologies within the veterinary pharmaceutical sector.

5. Export Potential

Develop the capability to supply veterinary hormones to global markets, positioning India as a competitive exporter.



Impact on the Livestock Sector

The project is expected to bring transformative benefits to India’s livestock ecosystem.

Improved Reproductive Efficiency

Veterinary reproductive hormones help regulate breeding cycles and treat infertility. With wider availability, farmers will be able to improve the reproductive health of animals, resulting in:

  • Higher calving rates

  • Better herd management

  • Increased milk and meat productivity

Strengthening Animal Healthcare

Indigenous hormone production will enhance the veterinary healthcare infrastructure and ensure consistent supply of critical therapeutics.

Supporting Farmer Livelihoods

By reducing costs and improving livestock productivity, the project can directly benefit farmers by increasing income from dairy and animal husbandry activities.

Technology Advancement

The project will promote biotechnology-driven innovation in veterinary medicine, strengthening India’s research and manufacturing capabilities.


Impact on the Indian Economy

The initiative has several broader economic implications.

Reduction in Import Dependence

Currently, India imports many specialized veterinary pharmaceuticals. Domestic production will significantly reduce foreign dependence and enhance supply chain resilience.

Foreign Exchange Savings

Indigenous manufacturing will generate substantial foreign exchange savings, which would otherwise be spent on imports.

Boost to the Biotechnology Industry

The project will stimulate growth in India’s biotechnology and veterinary pharmaceutical sector, encouraging more investments in research and development.

Export Opportunities

With commercial-scale production capabilities, India can become a supplier of veterinary hormones to developing countries with large livestock populations.

Rural Economic Growth

Since livestock farming supports millions of rural households, improvements in animal productivity will strengthen rural incomes and agricultural sustainability.

Conclusion

The Technology Development Board’s support for Biovet Pvt. Ltd. marks a significant milestone in India’s journey toward self-reliance in veterinary biotechnology. By enabling indigenous production of critical reproductive hormones, the initiative addresses long-standing gaps in animal healthcare and supports the modernization of India’s livestock sector.

Beyond technological advancement, the project carries the potential to transform rural livelihoods, reduce import dependence, strengthen biotechnology capabilities, and position India as an emerging global player in veterinary pharmaceuticals.

As India continues to invest in science-driven agricultural solutions, initiatives like this will play a key role in building a resilient, productive, and globally competitive livestock economy.


#Biotechnology #AnimalHusbandry #VeterinaryScience #AatmanirbharBharat #IndianInnovation #AgriTech #LivestockEconomy #ScienceForFarmers #AbhinandanWrites


Reference Link: https://www.pib.gov.in/PressReleasePage.aspx?PRID=2232624&reg=3&lang=1

Comments

Post a Comment

Popular posts from this blog

स्वधा स्तोत्र (Swadha Stotra)

स्वधा स्तोत्र तर्पण काल में स्वधा स्तोत्र का पाठ करने से पितरों को तृप्ति प्राप्त होतो है | समयाभाव के कारण यदि पूरा स्तोत्र का पाठ नहीं कर सकते है तब " स्वधा स्वधा स्वधा " ऐसा तीन बार उच्चारण करने से भी स्तोत्र पाठ का फल प्राप्त होता है | स्वधा स्तोत्र ब्रह्मोवाच – Brahmovach स्वधोच्चारणमात्रेण तीर्थस्नायी भवेन्नर:। मुच्यते सर्वपापेभ्यो वाजपेयफलं लभेत्।।1।। स्वधा स्वधा स्वधेत्येवं यदि वारत्रयं स्मरेत्। श्राद्धस्य फलमाप्नोति कालस्य तर्पणस्य च।।2।। श्राद्धकाले स्वधास्तोत्रं य: श्रृणोति समाहित:। लभेच्छ्राद्धशतानां च पुण्यमेव न संशय:।।3।। स्वधा स्वधा स्वधेत्येवं त्रिसन्ध्यं य: पठेन्नर:। प्रियां विनीतां स लभेत्साध्वीं पुत्रं गुणान्वितम्।।4।। पितृणां प्राणतुल्या त्वं द्विजजीवनरूपिणी। श्राद्धाधिष्ठातृदेवी च श्राद्धादीनां फलप्रदा।।5।। बहिर्गच्छ मन्मनस: पितृणां तुष्टिहेतवे। सम्प्रीतये द्विजातीनां गृहिणां वृद्धिहेतवे।।6।। नित्या त्वं नित्यस्वरूपासि गुणरूपासि सुव्रते। आविर्भावस्तिरोभाव: सृष्टौ च प्रलये तव।।7।। ऊँ स्वस्तिश्च नम: स्वाहा स्वधा त्वं दक्षिणा तथा। निरूपिताश्चतुर्वेदे षट् प्र...
Read more

MSCI 37 Key ESG Indicators

MSCI 37 Key ESG Indicators Introduction: 1 MSCI ESG Key Issues Overview 2 Environmental (E) 2 Social (S) 2 Governance (G) 2 MSCI evaluates companies using 37 key ESG (Environmental, Social, and Governance) issues: 3 Environmental (E) 3 1. Climate Change 3 2. Natural Resources 4 3. Pollution & Waste 4 4. Environmental Opportunities 4 Social (S) 4 5. Human Capital 5 6. Product Liability 5 7. Stakeholder Opposition 5 8. Social Opportunities 6 Governance (G) 6 9. Corporate Governance 6 10. Business Ethics 6 Introduction: MSCI (Morgan Stanley Capital International) evaluates companies using 37 key ESG (Environmental, Social, and Governance) issues to assess their resilience to financially relevant, industry-specific sustainability risks and opportunities. These issues are categorized into three pillars: Environmental, Social, and Governance, and further organized into ten themes. The ratings are based on a scale from AAA (highest) to CCC (lowest) .(...
Read more

ESG Implementation Timeline

  ESG Implementation Timeline ESG (Environmental, Social, and Governance) Implementation Timeline, adaptable for organizations starting their ESG journey or improving their existing practices. The timeline is spread across four phases over 12 to 24 months, depending on organizational size and readiness. Phase 1: Preparation & Commitment (Months 0–3) 1 1. Leadership Commitment 2 2. Initial ESG Awareness 2 3. Gap Analysis 2 4. Policy Review or Creation 2 Phase 2: Strategy & Integration (Months 4–8) 3 1. Define ESG Goals & KPIs 3 2. Develop ESG Roadmap 3 3. Data Systems Setup 3 4. Stakeholder Engagement Plan 3 Phase 3: Implementation (Months 9–15) 3 1. Launch ESG Initiatives 4 2. Train Employees 4 3. Monitor & Audit 4 4. Begin Reporting Systems 4 Phase 4: Reporting & Continuous Improvement (Months 16–24) 4 1. Public Disclosure 4 2. Third-Party Verification 5 3. Feedback & Refinement 5 4. Plan for Next Cycle 5 Optional: Fa...
Read more